Syreon understands first hand the importance and complexity of all phases of clinical research, and provides
outstanding expertise in study design, project management, site management, investigator training,
data management, study monitoring, on-line analysis and reporting.
|
|
- Market research, disease registries
track the natural history, current management and outcomes of patients with chronic disorders to monitor
risk factors, treatment choice and outcomes.
- Pre-marketing clinical trials (ph. I-lll)
incorporate cutting-edge pharmacology and laboratory sciences to evaluate the safety, efficacy and utility
of new treatments or indications.
- Post-marketing clinical trials (ph. IV)
speed safe and effective transition from research to clinical practice, and identify target populations,
treatment trends, outcomes and barriers to use.
- Special approval programs
provide access to new and specialized medication in the transitional phase pending marketing approval
according to defined guidelines or regulations.
- Disease management support
ensures comprehensive finger-tip information to clinical teams for management of chronic diseases to
support clinical guidelines, measure health outcomes and determine clinical and economic value.
|
